These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9628311)
1. Recurrent Pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronism. Marthinsen L; Kornfält R; Aili M; Andersson D; Westgren U; Schaedel C Acta Paediatr; 1998 Apr; 87(4):472-4. PubMed ID: 9628311 [TBL] [Abstract][Full Text] [Related]
2. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. Hanukoglu A; Bistritzer T; Rakover Y; Mandelberg A J Pediatr; 1994 Nov; 125(5 Pt 1):752-5. PubMed ID: 7965429 [TBL] [Abstract][Full Text] [Related]
3. Acute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisation. Dopfer C; Kentouche K; Gruhn B; Dopfer R; Becker S; Mentzel HJ; Beck JF; Mainz JG Klin Padiatr; 2011 Nov; 223(6):368-9. PubMed ID: 22012603 [No Abstract] [Full Text] [Related]
5. Clinico-pathological analysis of the cutaneous lesions of a patient with type I pseudohypoaldosteronism. Martín JM; Calduch L; Monteagudo C; Alonso V; García L; Jordá E J Eur Acad Dermatol Venereol; 2005 May; 19(3):377-9. PubMed ID: 15857472 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E; Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983 [TBL] [Abstract][Full Text] [Related]
7. Chinks in the armor of the airway: Pseudomonas infection in the cystic fibrosis lung. Ferkol TW; Look DC Am J Respir Cell Mol Biol; 2001 Jul; 25(1):11-3. PubMed ID: 11472969 [No Abstract] [Full Text] [Related]
8. Disseminated Pseudomonas aeruginosa and necrotizing pneumonia with complete recovery. Kumar PD; Ravakhah K; West BC South Med J; 2001 Feb; 94(2):229-32. PubMed ID: 11235039 [TBL] [Abstract][Full Text] [Related]
9. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests. Augarten A; Berman H; Aviram M; Diver-Habber A; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Katznelson D; Szeinberg A; Kerem BS; Theodor L; Paret G; Yahav Y Clin Exp Med; 2003 Sep; 3(2):119-23. PubMed ID: 14598187 [TBL] [Abstract][Full Text] [Related]
10. Update on treatment of pulmonary exacerbations in cystic fibrosis. Smyth A Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495 [TBL] [Abstract][Full Text] [Related]
11. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis. Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764 [TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Moser C; Jensen PØ; Pressler T; Frederiksen B; Lanng S; Kharazmi A; Koch C; Høiby N APMIS; 2005 Jun; 113(6):400-9. PubMed ID: 15996157 [TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis and novel possibilities of diagnosis of cystic fibrosis]. Kilian K; Kisiel BM Pol Merkur Lekarski; 2006 May; 20(119):582-5. PubMed ID: 16875168 [TBL] [Abstract][Full Text] [Related]
14. Pyopneumothorax as a complication of Pseudomonas aeruginosa bronchopneumonia: a case report. Schwarz KO; Thung SN; Marinescu A Mt Sinai J Med; 1981; 48(2):146-8. PubMed ID: 6971407 [No Abstract] [Full Text] [Related]
15. Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. Santos RP; Awa E; Anbar RD BMC Pediatr; 2007 Mar; 7():11. PubMed ID: 17331261 [TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis. Segal I; Yaakov Y; Adler SN; Blau H; Broide E; Santo M; Yahav Y; Klar A; Lerner A; Aviram M; Ellis I; Mountford R; Shteyer E; Kerem E; Wilschanski M J Clin Gastroenterol; 2008 Aug; 42(7):810-4. PubMed ID: 18360295 [TBL] [Abstract][Full Text] [Related]
17. Case study: cystic fibrosis. Bowling SA Am J Med Technol; 1982 Jan; 48(1):25-7. PubMed ID: 7072751 [No Abstract] [Full Text] [Related]
18. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346 [TBL] [Abstract][Full Text] [Related]
20. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis]. Kernen Y; Sauty A; Roulet M Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]